The rising prevalence of cardiovascular diseases worldwide is a major driver of the bioabsorbable stents market. Furthermore, the increased risk of late stent thrombosis and restenosis due to the use of conventional drug eluting stents is encouraging the use of new advanced biodegradable stents that degrade over time. According to the American Heart Association (AHA), the mortality rate from late stent thrombosis was around 45 percent in 2008. Other factors driving the growth of the bioabsorbable stents market include an increase in the geriatric population, who are more susceptible to strokes and cardiovascular diseases that necessitate stent implantation, technological advancements in stents, and a rising adoption rate of bioabsorbable stents.
Read More:
https://knackersblogger.blogspot.com/2022/08/the-increase-in-prevalence-of.html
